However, a remarkable disparity is evident in the P53 protein staining (p < 0.001), with 100% (49 cases) of high-grade serous carcinoma patients being P53-positive and 100% (48 cases) of patients with other malignant epithelial tumors being P53-negative. This evidence concerns the gene TP53 and serous adenocarcinoma.